BTG1P1

Across TCGA pan-cancer cohorts, BTG1P1 RNA differs between tumor and matched normal tissue in 12 of 18 cancer types tested, making tumor–normal expression one of BTG1P1’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where BTG1P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types BTG1P1 is over-expressed in tumor, although a few such as LUSC and BLCA show the opposite, repressed pattern.

KIRC, LUSC, and BLCA are the cancer types where BTG1P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in BTG1P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Female	All	+0.291	<.001	10	view →
LUSC	All	II,III,IV	−0.537	<.001	8	view →
BLCA	All	All	−0.281	.001	8	view →
KICH	All	IV	−0.252	.003	8	view →
LUAD	All	II,III,IV	−0.423	<.001	7	view →
THCA	All	All	−0.241	<.001	6	view →
CHOL	All	All	−0.913	<.001	2	view →
LIHC	Male	All	+0.699	<.001	2	view →
COAD	All	III,IV	−0.219	.013	2	view →
BRCA	All	III,IV	−0.198	.025	2	view →
KIRP	All	All	+0.168	.009	2	view →
UCEC	All	All	−0.157	.028	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 12 lineages.

BTG1P1–KIRC

Open the KIRC breakdown →